open access

Vol 24, No 4 (2018)
Original papers
Published online: 2018-12-05
Get Citation

Effectiveness of enhanced external counter pulsation on clinical profile and health-related quality of life in patients with coronary heart disease: a systematic review

Vikram Singh, Girija Kumari, Bimal Chhajer, Ashok Kumar Jhingan, Saurabh Dahiya
DOI: 10.5603/AA.2018.0021
·
Acta Angiologica 2018;24(4):105-122.

open access

Vol 24, No 4 (2018)
Original papers
Published online: 2018-12-05

Abstract

Introduction. Enhanced External Counter Pulsation (EECP) is a non-invasive United States Food and Drug
Administration (FDA) approved outpatient treatment option for the complex problem of angina, a common
symptom of coronary heart disease. A systematic review of the literature searched to assess the effect of EECP
on the clinical profile that comprised physiological measurements, biochemical assessments, cardiac clinical
symptoms, physical functional status, and Health-Related Quality of Life (HRQoL) in Coronary Heart Disease
(CHD) patients.


Material and methods. Total 258 EECP research articles from the early stage of EECP development to till
date screened. Out of 258 EECP articles, total 60 articles (53 EECP articles for clinical profile and 7 article for
HRQoL matched the inclusion criteria and other (n = 198) articles excluded due to irrelevant to study objectives.

Results. All enrolled studies showed a significant improvement in angina pectoris and HRQoL with reduction
of nitroglycerine use and exercise tolerance. There are several gaps in research has been found for further
research to evaluate the EECP effectiveness on Body Mass Index (BMI), Heart Rate, Cholesterol, Triglyceride,
High Density Lipoprotein (HDL), Low Density Lipoprotein (LDL), HbA1C, SpO2, Vo2max level with a comparative
assessment of cardiac and non-cardiac metabolic markers including blood glucose.

Conclusions. There is further need of multi-centric randomize controlled trial studies to evaluate the effect
of EECP on obese, diabetic, hypertension and other metabolic disease patients and more research required for
further modifications in EECP device to cure, prevent and treat chronic diseases by the non-invasive procedure.

Abstract

Introduction. Enhanced External Counter Pulsation (EECP) is a non-invasive United States Food and Drug
Administration (FDA) approved outpatient treatment option for the complex problem of angina, a common
symptom of coronary heart disease. A systematic review of the literature searched to assess the effect of EECP
on the clinical profile that comprised physiological measurements, biochemical assessments, cardiac clinical
symptoms, physical functional status, and Health-Related Quality of Life (HRQoL) in Coronary Heart Disease
(CHD) patients.


Material and methods. Total 258 EECP research articles from the early stage of EECP development to till
date screened. Out of 258 EECP articles, total 60 articles (53 EECP articles for clinical profile and 7 article for
HRQoL matched the inclusion criteria and other (n = 198) articles excluded due to irrelevant to study objectives.

Results. All enrolled studies showed a significant improvement in angina pectoris and HRQoL with reduction
of nitroglycerine use and exercise tolerance. There are several gaps in research has been found for further
research to evaluate the EECP effectiveness on Body Mass Index (BMI), Heart Rate, Cholesterol, Triglyceride,
High Density Lipoprotein (HDL), Low Density Lipoprotein (LDL), HbA1C, SpO2, Vo2max level with a comparative
assessment of cardiac and non-cardiac metabolic markers including blood glucose.

Conclusions. There is further need of multi-centric randomize controlled trial studies to evaluate the effect
of EECP on obese, diabetic, hypertension and other metabolic disease patients and more research required for
further modifications in EECP device to cure, prevent and treat chronic diseases by the non-invasive procedure.

Get Citation

Keywords

enhanced external counter pulsation, angina pectoris, health-related quality of life,coronary heart disease

About this article
Title

Effectiveness of enhanced external counter pulsation on clinical profile and health-related quality of life in patients with coronary heart disease: a systematic review

Journal

Acta Angiologica

Issue

Vol 24, No 4 (2018)

Pages

105-122

Published online

2018-12-05

DOI

10.5603/AA.2018.0021

Bibliographic record

Acta Angiologica 2018;24(4):105-122.

Keywords

enhanced external counter pulsation
angina pectoris
health-related quality of life
coronary heart disease

Authors

Vikram Singh
Girija Kumari
Bimal Chhajer
Ashok Kumar Jhingan
Saurabh Dahiya

References (71)
  1. Gupta R, Mohan I, Narula J. Trends in Coronary Heart Disease Epidemiology in India. Ann Glob Health. 2016; 82(2): 307–315.
  2. Pradhan A. Cardiovascular risk screening: Time for a wakeup call! Heart India. 2016; 4(1): 3.
  3. Prasad GN, Ramasamy S, Thomas JM, et al. Enhanced external counterpulsation (EECP) therapy: current evidence for clinical practice and who will benefit? Indian Heart J. 2010; 62(4): 296–302.
  4. Kantrowitz A. Experimental augmentation of coronary flow by retardation of the arterial pressure pulse. Surgery. 1953; 34(4): 678–687.
  5. Birtwell WC, Ruitz U, Soroff HS. Technical consideration in the design of a clinical system for external left ventricular assist by synchronous pulsation of extramural pressure. Surg Forum. 1965; 16: 148–150.
  6. Birtwell WC, Ruiz U, Soroff HS, et al. Technical consideration in the design of a clinical system for the external left ventricular assist. Trans Am SocArtif Intern Organs. 1968; 14: 304–310.
  7. Zheng ZS, Li TM, Kambic H, et al. Sequential external counterpulsation (SECP) in China. Trans Am Soc Artif Intern Organs. 1983; 29: 599–603.
  8. Kumar S, Lahiri TK. Enhanced external counter pulsation as an effective nonsurgical solution for ischemic heart disease patients. Heart India. 2017; 5: 55–60.
  9. Prasad GN, Ramasamy S, Thomas JM, et al. Enhanced external counterpulsation (EECP) therapy: current evidence for clinical practice and who will benefit? Indian Heart J. 2010; 62(4): 296–302.
  10. Sayami LA, Ullah M, Rahman MT, et al. Enhanced External Counterpulsation - A Review. Cardiovascular Journal. 2010; 2(2): 236–244.
  11. Manchanda A, Soran O. Enhanced external counterpulsation and future directions: step beyond medical management for patients with angina and heart failure. J Am Coll Cardiol. 2007; 50(16): 1523–1531.
  12. Michaels AD, McCullough PA, Soran OZ, et al. International EECP Patient Registry Investigators. Efficacy of enhanced external counterpulsation in the treatment of angina pectoris. Am J Cardiol. 1992; 70(9): 859–862.
  13. Karim S, Sani A, Karo-Karo S, et al. Enhanced External Counterpulsation in the Treatment and Rehabilitation of Coronary Patients in Indonesia. Asian Cardiovascular and Thoracic Annals. 2016; 3(1): 26–28.
  14. Arora RR, Chou TM, Jain D, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol. 1999; 33(7): 1833–1840.
  15. Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology. 2000; 94(1): 31–35.
  16. Lawson WE, Hui JC, Cohn PF. Long-term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up study. Clin Cardiol. 2000; 23(4): 254–258.
  17. Urano H, Ikeda H, Ueno T, et al. Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol. 2001; 37(1): 93–99.
  18. Stys TP, Lawson WE, Hui JCK. Safety and effectiveness of enhanced external counterpulsation in improving angioplasty restenosis. proceedings of the 2nd international congress on heart disease – new trends in research, diagnosis and treatment. International Academy of Cardiology. 2001; 24: 369–372.
  19. Barsness G, Feldman AM, Holmes DR, et al. International EECP Patient Registry Investigators. The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results. Clin Cardiol. 2001; 24(6): 435–442.
  20. Springer S, Fife A, Lawson W, et al. Psychosocial effects of enhanced external counterpulsation in the angina patient: a second study. Psychosomatics. 2001; 42(2): 124–132.
  21. Lakshmi MV, Kennard ED, Kelsey SF, et al. Relation of the pattern of diastolic augmentation during a course of enhanced external counterpulsation (EECP) to clinical benefit (from the International EECP Patient Registry [IEPR]). Am J Cardiol. 2002; 89(11): 1303–1305.
  22. Stys TP, Lawson WE, Hui JCK, et al. Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. Am J Cardiol. 2002; 89(7): 822–824.
  23. Michaels AD, Accad M, Ports TA, et al. Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation. Circulation. 2002; 106(10): 1237–1242.
  24. Holubkov R, Kennard ED, Foris JM, et al. Comparison of patients undergoing enhanced external counterpulsation and percutaneous coronary intervention for stable angina pectoris. Am J Cardiol. 2002; 89(10): 1182–1186.
  25. Soran O, Fleishman B, Demarco T, et al. Enhanced external counterpulsation in patients with heart failure: a multicenter feasibility study. Congest Heart Fail. 2002; 8(4): 204–227.
  26. Fitzgerald CP, Lawson WE, Hui JCK, et al. IEPR Investigators. Enhanced external counterpulsation as initial revascularization treatment for angina refractory to medical therapy. Cardiology. 2003; 100(3): 129–135.
  27. Bonetti P, Holmes D, Lerman A, et al. Enhanced external counterpulsation for ischemic heart disease. Journal of the American College of Cardiology. 2003; 41(11): 1918–1925.
  28. Shechter M, Matetzky S, Feinberg M, et al. External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris. Journal of the American College of Cardiology. 2003; 41(6): 269.
  29. Tartaglia J, Stenerson J, Charney R, et al. Exercise capability and myocardial perfusion in chronic angina patients treated with enhanced external counterpulsation. Clin Cardiol. 2003; 26(6): 287–290.
  30. Werner D, Marthol H, Brown CM, et al. Changes of cerebral blood flow velocities during enhanced external counterpulsation. Acta Neurol Scand. 2003; 107(6): 405–411.
  31. Lawson WE, Kennard ED, Hui JCK, et al. IEPR Investigators. Analysis of baseline factors associated with reduction in chest pain in patients with angina pectoris treated by enhanced external counterpulsation. Am J Cardiol. 2003; 92(4): 439–443.
  32. Linnemeier G, Rutter MK, Barsness G, et al. IEPR Investigators. Enhanced External Counterpulsation for the relief of angina in patients with diabetes: safety, efficacy and 1-year clinical outcomes. Am Heart J. 2003; 146(3): 453–458.
  33. Linnemeier G, Michaels A, Soran O, et al. Enhanced External Counterpulsation in the Management of Angina in the Elderly. The American Journal of Geriatric Cardiology. 2003; 12(2): 90–96.
  34. Bagger JP, Hall RJC, Koutroulis G, et al. Effect of enhanced external counterpulsation on dobutamine-induced left ventricular wall motion abnormalities in severe chronic angina pectoris. Am J Cardiol. 2004; 93(4): 465–467.
  35. Michaels AD, Linnemeier G, Soran O, et al. Two-year outcomes after enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry [IEPR]). Am J Cardiol. 2004; 93(4): 461–464.
  36. Lawson WE, Hui JCK, Barsness GW, et al. IEPR Investigators. Effectiveness of enhanced external counterpulsation in patients with left main disease and angina. Clin Cardiol. 2004; 27(8): 459–463.
  37. Masuda D, Fujita M, Nohara R, et al. Improvement of oxygen metabolism in ischemic myocardium as a result of enhanced external counterpulsation with heparin pretreatment for patients with stable angina. Heart Vessels. 2004; 19(2): 59–62.
  38. Henrikson CA, Chandra-Strobos N. Enhanced external counterpulsation therapy: significant clinical improvement without electrophysiologic remodeling. Ann Noninvasive Electrocardiol. 2004; 9(3): 265–269.
  39. Taguchi I, Ogawa K, Kanaya T, et al. Effects of enhanced external counterpulsation on hemodynamics and its mechanism. Circ J. 2004; 68(11): 1030–1034.
  40. Lawson WE, Silver MA, Hui JCK, et al. Angina patients with diastolic versus systolic heart failure demonstrate comparable immediate and one-year benefit from enhanced external counterpulsation. J Card Fail. 2005; 11(1): 61–66.
  41. Michaels AD, Raisinghani A, Soran O, et al. The effects of enhanced external counterpulsation on myocardial perfusion in patients with stable angina: a multicenter radionuclide study. Am Heart J. 2005; 150(5): 1066–1073.
  42. Arora R, Chen HJ, Rabbani L. Effects of enhanced counterpulsation on vascular cell release of coagulation factors. Heart Lung. 2005; 34(4): 252–256.
  43. McCullough PA, Silver MA, Kennard ED, et al. IEPR Investigators. Impact of body mass index on outcomes of enhanced external counterpulsation therapy. Am Heart J. 2006; 151(1): 139.
  44. Akhtar M, Wu GF, Du ZM, et al. Effect of external counterpulsation on plasma nitric oxide and endothelin-1 levels. Am J Cardiol. 2006; 98(1): 28–30.
  45. Soran O, Kennard ED, Kfoury AG, et al. IEPR Investigators. Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry). Am J Cardiol. 2006; 97(1): 17–20.
  46. Nichols WW, Estrada JC, Braith RW, et al. Enhanced external counterpulsation treatment improves arterial wall properties and wave reflection characteristics in patients with refractory angina. J Am Coll Cardiol. 2006; 48(6): 1208–1214.
  47. Lawson WE, Hui JCK, Kennard ED, et al. International Enhanced External Counterpulsation Patient Registry Investigators. Two-year outcomes in patients with mild refractory angina treated with enhanced external counterpulsation. Clin Cardiol. 2006; 29(2): 69–73.
  48. Novo G, Bagger JP, Carta R, et al. Enhanced external counterpulsation for treatment of refractory angina pectoris. J Cardiovasc Med (Hagerstown). 2006; 7(5): 335–339.
  49. Loh PH, Louis AA, Windram J, et al. The immediate and long-term outcome of enhanced external counterpulsation in treatment of chronic stable refractory angina. J Intern Med. 2006; 259(3): 276–284.
  50. Arora RR, Bergmann S. Effects of enhanced external counterpulsation (EECP) on myocardial perfusion. Am J Ther. 2007; 14(6): 519–523.
  51. Michaels AD, McCullough PA, Soran OZ, et al. Primer: practical approach to the selection of patients for and application of EECP. Nat Clin Pract Cardiovasc Med. 2006; 3(11): 623–632.
  52. McCullough PA, Henry TD, Kennard ED, et al. IEPR Investigators. Residual high-grade angina after enhanced external counterpulsation therapy. Cardiovasc Revasc Med. 2007; 8(3): 161–165.
  53. Yavari M, Montazeri HR. Effects of enhanced external counterpulsation on anginal symptoms and improvements in objective measures of myocardial ischaemia. Cardiovasc J Afr. 2007; 18(3): 154–156.
  54. Loh PH, Cleland JGF, Louis AA, et al. Enhanced external counterpulsation in the treatment of chronic refractory angina: a long-term follow-up outcome from the International Enhanced External Counterpulsation Patient Registry. Clin Cardiol. 2008; 31(4): 159–164.
  55. Erdling A, Bondesson S, Pettersson T, et al. Enhanced external counter pulsation in treatment of refractory angina pectoris: two year outcome and baseline factors associated with treatment failure. BMC Cardiovasc Disord. 2008; 8: 39.
  56. Buschmann EE, Utz W, Pagonas N, et al. Arteriogenesis Network (Art. Net.). Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation (Art.Net.-2 Trial). Eur J Clin Invest. 2009; 39(10): 866–875.
  57. Esmaeilzadeh M, Khaledifar A, Maleki M, et al. Evaluation of left ventricular systolic and diastolic regional function after enhanced external counter pulsation therapy using strain rate imaging. Eur J Echocardiogr. 2009; 10(1): 120–126.
  58. Soran O, Ikizler C, Sengül A, et al. Comparison of long term clinical outcomes, event free survival rates of patients undergoing enhanced external counterpulsation for coronary artery disease in the United States and Turkey. Turk Kardiyol Dern Ars. 2012; 40(4): 323–330.
  59. Eslamian F, Aslanabadi N, Mahmoudian B, et al. Therapeutic effects of Enhanced External Counter Pulsation (EECP) on clinical symptoms, echocardiographic measurements, perfusion scan parameters and exercise tolerance test in coronary artery disease patients with refractory angina. International Journal of Medical Science and Public Health. 2013; 2(2): 187.
  60. Bozorgi A, Mehrabi Nasab E, Sardari A, et al. Effect of Enhanced External Counterpulsation (EECP) on Exercise Time Duration and Functional Capacity in Patients with Refractory Angina Pectoris. J Tehran Heart Cent. 2014; 9(1): 33–37.
  61. Beck DT, Martin JS, Casey DP, et al. Enhanced external counterpulsation improves endothelial function and exercise capacity in patients with ischaemic left ventricular dysfunction. Clin Exp Pharmacol Physiol. 2014; 41(9): 628–636.
  62. Tabary S, Yousefnejad K. Assessment the clinical and paraclinical effects of enhanced external counter pulsation therapy in patients with coronary artery disease. Int J Med Invest. 2015; 4(2): 245–248.
  63. Subramanian R. Effect of EECP treatment on aortic blood pressure, arterial stiffness and EF in patients with CAD. Journal of Clinical and Diagnostic Research. 2016; 10(10): 30–34.
  64. Beck DT, Casey DP, Martin JS, et al. Enhanced external counterpulsation reduces indices of central blood pressure and myocardial oxygen demand in patients with left ventricular dysfunction. Clin Exp Pharmacol Physiol. 2015; 42(4): 315–320.
  65. Arora RR, Chou TM, Jain D, et al. Effects of enhanced external counterpulsation on Health-Related Quality of Life continue 12 months after treatment: a substudy of the Multicenter Study of Enhanced External Counterpulsation. J Investig Med. 2002; 50(1): 25–32.
  66. Kumar A, Aronow WS, Vadnerkar A, et al. Effect of enhanced external counterpulsation on clinical symptoms, quality of life, 6-minute walking distance, and echocardiographic measurements of left ventricular systolic and diastolic function after 35 days of treatment and at 1-year follow up in 47 patients with chronic refractory angina pectoris. Am J Ther. 2009; 16(2): 116–118.
  67. Wu E, Mårtensson J, Broström A. Enhanced external counterpulsation in patients with refractory angina pectoris: a pilot study with six months follow-up regarding physical capacity and health-related quality of life. Eur J Cardiovasc Nurs. 2013; 12(5): 437–445.
  68. Ziaeirad M, Ziaei GR, Sadeghi N, et al. The effects of enhanced external counterpulsation on health-related quality of life in patients with angina pectoris. Iran J Nurs Midwifery Res. 2012; 17(1): 41–46.
  69. Jorgensen MT, May O. Improvement of angina, quality of life, and working capacity after enhanced external counterpulsation. UgeskrLaeger. 2013; 175(3): 114–16.
  70. May O, Lynggaard V, Mortensen JCA, et al. Enhanced external counterpulsation - effect on angina pectoris, QoL and exercise capacity after 1 year. Scand Cardiovasc J. 2015; 49(1): 1–6.
  71. Shakouri SK, Razavi Z, Eslamian F, et al. Effect of Enhanced External Counterpulsation and Cardiac Rehabilitation on Quality of Life, Plasma Nitric Oxide, Endothelin 1 and High Sensitive CRP in Patients With Coronary Artery Disease: A Pilot Study. Ann Rehabil Med. 2015; 39(2): 191–198.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl